Johnson & Johnson (JNJ) Times Interest Earned (2009 - 2026)
Johnson & Johnson (JNJ) posted Times Interest Earned of $2.04 for Q2 2026, up 12.21% sequentially from $1.82 in Q1 2026, and down 20.19% YoY from $2.56 in Q2 2025.
Johnson & Johnson (JNJ) Times Interest Earned (2009 - 2026) Analysis & Trends
Johnson & Johnson has reported Times Interest Earned for 18 years, with the latest figure at $2.04 in Q2 2026.
- Quarterly Times Interest Earned fell 20.19% year-over-year to $2.04 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $7.44 (down 9.87% YoY) and the FY2025 annual result came in at $4.83, down 49.48% from the prior year.
- Times Interest Earned rose to $2.04 in Q2 2026 per JNJ's latest filing, from $1.82 in the prior quarter.
- Over five years, Times Interest Earned peaked at $71.7 in Q1 2023 and troughed at -$11.87 in Q4 2023.
- A 5-year average of $5.02 and a median of $2.5 in 2023 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2023 and 2025: Times Interest Earned slumped 116.56% in 2023, then jumped 142.14% in 2025.
- Over 5 years, Times Interest Earned stood at $1.89 in 2022, then slumped by 727.44% to -$11.87 in 2023, then grew by 9.79% to -$10.71 in 2024, then surged by 142.14% to $4.51 in 2025, then plunged by 54.81% to $2.04 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered $2.04, $1.82, and $4.51 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 25.41 |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | - |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 10.28 |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 7.27 |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 5.22 |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | -42.08 |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | - |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | -2.64 |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn | -50.26 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | 2.04 |
| Mar 29, 2026 | 1.82 |
| Dec 28, 2025 | 4.51 |
| Sep 28, 2025 | 2.81 |
| Jun 29, 2025 | 2.56 |
| Mar 30, 2025 | 2.81 |
| Dec 29, 2024 | -10.71 |
| Sep 29, 2024 | 2.52 |
| Jun 30, 2024 | 3.24 |
| Mar 31, 2024 | 3.69 |
| Dec 31, 2023 | -11.87 |
| Oct 1, 2023 | 2.50 |
| Jul 2, 2023 | 2.24 |
| Apr 2, 2023 | 2.20 |
| Jan 1, 2023 | 71.70 |
| Oct 2, 2022 | 1.89 |
| Apr 3, 2022 | 1.45 |
| Oct 3, 2021 | 1.84 |
| Jul 4, 2021 | 1.72 |
| Apr 4, 2021 | 1.61 |